An Act relative to prescription medication re-authorization

This bill prohibits licensed health insurers in Massachusetts from requiring annual re-authorization for specific prescription drugs used to treat chronic conditions such as diabetes, heart disease, and cancer. It directly affects patients with these long-term illnesses by preventing insurance companies from forcing them to repeatedly renew their coverage for essential medications every year. The law applies to insurers operating under state chapters 32A, 118E, 175, 176A, 176B, and 176G, ensuring that once a doctor prescribes these drugs, the patient can continue taking them without interruption. By removing the administrative hurdle of yearly re-approval, the legislation aims to streamline access to necessary treatments for individuals managing chronic diseases.